Springs, CO 80932-0688
following gynecological cancer statistics were collected from the
website of the National
Cancer Institute and its associated web sites including CancerNet
and are ranked in order of lifetime risk of diagnosis.
Leiomyosarcoma/Uterine Sarcoma (stats
combined due to rarity)
cases per 100,000 white women per year; 15.3 cases per 100,000 black
women per year (1992-1996).
most common cause of cancer among women in the United States.
Lifetime risk of diagnosis is 2.68% for all races, 2.85% for whites
and 1.72 in black women. (SEER stats for 1993-1997)
Lifetime risk of death is .51 % for all races, .49% for whites,
and .71% for black women. (SEER stats for 1993-1997)
There were an estimated 36,100 new cases expected in the year
Risk increases with increasing age in most racial groups.
age is 45 years.
Most common among Hawaiians, Japanese and white women.
Lowest rates are among Korean, Vietnamese, and American Indian
risk factor is usage of exogenous menopausal estrogens.
Highest in North America and northern Europe.
in Asia and Africa.
Marked increase and peak in 1975 and a decline thereof possibly
resulting from use of estrogen replacement therapy.
Risk factors include high socioeconomic status and never given
birth or few pregnancies.
decrease in risk has been observed in women with multiple births.
with obesity and possibly with abnormal glucose tolerance.
Obesity, associated with increased levels of estrogen, has been
linked to increasing risk of endometrial cancer.
deaths per 100,000 population per year (white); 6 deaths per 100,000
population per year (black).
There were expected approximately 6,500 deaths in the year 2000.
Highest among Hawaiian women, followed by black women.
survive after the first year.
survive after 5 years (if detected at an early stage).
survive if detected during the regional stage.
per 100,000 female population per year (white)
10.3 per 100,000 (black)
in incidence among women in the United States.
Lifetime risk of being diagnosed with ovarian cancer is 1.71%
for all races: 1.82% for whites, and 1.04% for black women. (SEER
stats for 1993-1997)
Lifetime risk of dying from ovarian cancer is 1.04% for all races:
1.09% for whites, and .75% for black women. (SEER stats for 1993-1997)
In 1994, there were approximately 24,000 new cases of ovarian
cancer in the U.S.
Women with breast cancer have a 70% risk of getting ovarian cancer.
Incidence increases with age and risk is three to five times greater
in women whose mother or sister has developed ovarian cancer.
and menstrual factors affect the risk of developing ovarian cancer.
Women with more full-term pregnancies (usually 3 or greater) have
about half the risk of those with none. Average reduction in risk
is approximately 13-19% per pregnancy. Oral contraceptives may
decrease risk while women with difficulties getting pregnant have
an increased risk.
Dietary fats may cause a slight increase in risk.
Age at first birth, age at menarche and menopause, alcohol, coffee
and tobacco have little or no risk.
Incidence rates are highest among American Indian women, followed
by white, Vietnamese, white Hispanic, and Hawaiian women. Lowest
rates are among Korean and Chinese women.
1994, there were 13,600 deaths from ovarian cancer. These rates have
declined slightly over the years. Mortality rates are highest among
white women, followed by Hawaiian and black women.
per 100,000 population per year (white)
6.5 per 100,000 population per year (black)
year survival rate for all races is 42% (1994).
of American women are diagnosed with cervical cancer.
of cervical cancers are diagnosed at the in situ stage.
cases per 100,000 population per year.
cases per 100,000 population (white).
cases per 100,000 population (black).
risk of diagnosis is .85% for all races, .78% for whites and 1.12%
for black women (SEER stats for 1993-1997).
Lifetime risk of death is .31 % for all races, .27% for whites,
and .58% for black women. (SEER stats for 1993-1997)
Incidence and mortality for invasive cervical cancer have declined
about 40% since the 1970's. Mortality declined right before PAP
smears became widely used.
Highest incidence rates are 43 cases per 100,000 population in
Vietnamese women (1987-1991).
Lowest incidence rates are 5.8 cases per 100,000 population in
Japanese women (1987-1991).
Risk factors are early age at initiation of sexual activity, multiple
sex partners, infection with the human papilloma virus 16, and
intake of vitamin C and beta carotene may increase risk of cervical
in all women.
in black women.
deaths per 100,000 population per year (white).
deaths per 100,000 population per year (black).
deaths expected in year 2000.
Mortality rates are about 50-80% lower than incidence rates.
Black women have the highest mortality rate.
Lowest mortality rate occurs among Japanese women.
Highest mortality rates in Mexico and central America.
Survival Rates (5 year
survival rate 1987-1991)
rates may be affected by socioeconomic status and sexual behavior.
Sarcoma (combined statistics)
women per 100,000 female population per year are diagnosed with
of all sarcoma cases are leiomyosarcoma.
Less than 1% of gynecologic malignancies are uterine sarcoma.
Age of onset is typically from 45-55 years of age.
10-25% of the cases are due to prior pelvic radiation.
5 year survival rate for patients with stage l disease is 50%.
Survival rate for patients in the remaining stages are 0-20.